RhumbLine Advisers
ITCI

RhumbLine Advisers’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-125,239
Closed -$16.5M 4314
2025
Q1
$16.5M Sell
125,239
-405
-0.3% -$53.4K 0.02% 793
2024
Q4
$10.5M Sell
125,644
-514
-0.4% -$42.9K 0.01% 1032
2024
Q3
$9.23M Buy
126,158
+962
+0.8% +$70.4K 0.01% 1104
2024
Q2
$8.57M Sell
125,196
-11,892
-9% -$814K 0.01% 1107
2024
Q1
$9.49M Buy
137,088
+2,197
+2% +$152K 0.01% 1072
2023
Q4
$9.66M Sell
134,891
-2,371
-2% -$170K 0.01% 1077
2023
Q3
$7.15M Buy
137,262
+2,809
+2% +$146K 0.01% 1155
2023
Q2
$8.51M Buy
134,453
+6,136
+5% +$389K 0.01% 1089
2023
Q1
$6.95M Buy
128,317
+370
+0.3% +$20K 0.01% 1154
2022
Q4
$6.77M Buy
127,947
+5,919
+5% +$313K 0.01% 1118
2022
Q3
$5.68M Buy
122,028
+9,742
+9% +$453K 0.01% 1153
2022
Q2
$6.41M Buy
112,286
+24,404
+28% +$1.39M 0.01% 1122
2022
Q1
$5.38M Buy
87,882
+11,643
+15% +$712K 0.01% 1267
2021
Q4
$3.99M Sell
76,239
-957
-1% -$50.1K ﹤0.01% 1498
2021
Q3
$2.88M Buy
77,196
+3,330
+5% +$124K ﹤0.01% 1684
2021
Q2
$3.02M Sell
73,866
-20,160
-21% -$823K ﹤0.01% 1726
2021
Q1
$3.19M Sell
94,026
-7,617
-7% -$258K ﹤0.01% 1658
2020
Q4
$3.23M Buy
101,643
+12,189
+14% +$388K ﹤0.01% 1606
2020
Q3
$2.3M Sell
89,454
-11,303
-11% -$290K ﹤0.01% 1599
2020
Q2
$2.59M Buy
100,757
+18,476
+22% +$474K ﹤0.01% 1585
2020
Q1
$1.27M Buy
82,281
+13,920
+20% +$214K ﹤0.01% 1775
2019
Q4
$2.35M Buy
68,361
+1,017
+2% +$34.9K ﹤0.01% 1711
2019
Q3
$503K Buy
67,344
+3,740
+6% +$27.9K ﹤0.01% 2322
2019
Q2
$826K Buy
63,604
+3,238
+5% +$42.1K ﹤0.01% 2142
2019
Q1
$735K Sell
60,366
-506
-0.8% -$6.16K ﹤0.01% 2163
2018
Q4
$693K Buy
60,872
+18,481
+44% +$210K ﹤0.01% 2155
2018
Q3
$920K Sell
42,391
-9,205
-18% -$200K ﹤0.01% 2036
2018
Q2
$912K Buy
51,596
+8,780
+21% +$155K ﹤0.01% 2044
2018
Q1
$901K Sell
42,816
-371
-0.9% -$7.81K ﹤0.01% 1990
2017
Q4
$625K Sell
43,187
-489
-1% -$7.08K ﹤0.01% 2147
2017
Q3
$689K Buy
43,676
+380
+0.9% +$6K ﹤0.01% 2162
2017
Q2
$538K Buy
43,296
+1,455
+3% +$18.1K ﹤0.01% 2253
2017
Q1
$680K Buy
41,841
+1,445
+4% +$23.5K ﹤0.01% 2121
2016
Q4
$610K Buy
40,396
+1,908
+5% +$28.8K ﹤0.01% 2119
2016
Q3
$587K Buy
38,488
+5,207
+16% +$79.4K ﹤0.01% 2109
2016
Q2
$1.29M Buy
33,281
+7,098
+27% +$276K ﹤0.01% 1628
2016
Q1
$728K Buy
26,183
+680
+3% +$18.9K ﹤0.01% 1988
2015
Q4
$1.37M Buy
25,503
+6,345
+33% +$341K ﹤0.01% 1602
2015
Q3
$767K Buy
19,158
+703
+4% +$28.1K ﹤0.01% 1948
2015
Q2
$590K Buy
18,455
+3,500
+23% +$112K ﹤0.01% 2224
2015
Q1
$357K Buy
14,955
+2,800
+23% +$66.8K ﹤0.01% 2514
2014
Q4
$215K Buy
12,155
+425
+4% +$7.52K ﹤0.01% 2777
2014
Q3
$161K Hold
11,730
﹤0.01% 2828
2014
Q2
$198K Buy
+11,730
New +$198K ﹤0.01% 2844